Table 2.
Effects of Long- and Short-Term Use of CGM on Nonsevere Hypoglycemia
| Long-term CGM users(≥3 months)(n = 34) | Short-term CGM users(<3 months)(n = 43) | |||
|---|---|---|---|---|
| Hypoglycemia at CGM start | Follow-up hypoglycemia value | Hypoglycemia at CGM start | Follow-up hypoglycemia value | |
| Hypoglycemia at CGM start | ||||
| 0 to <5 | 8 (30.8%) | 11 (42.3%) | 12 (29.3%) | 12 (29.3%) |
| 5 to <10 | 6 (23.1%) | 12 (46.2%) | 8 (19.5%) | 10 (24.4%) |
| 10 to <15 | 5 (19.2%) | 1 (3.8%) | 15 (36.6%) | 11 (26.8%) |
| ≥15 | 7 (26.9%) | 2 (7.7%) | 6 (14.6%) | 8 (19.5%) |
| Missing | 8 | 8 | 2 | 2 |
| Change in hypoglycemia from CGM start to follow-up valuea,b | ||||
| Reduction in hypoglycemia (2 × 5-step scale) | 7 (26.9%) | 5 (12.2%) | ||
| Reduction in hypoglycemia (1 × 5-step scale) | 6 (23.1%) | 4 (9.8%) | ||
| Hypoglycemia cases within the same 5-step scale | 10 (38.5%) | 21 (51.2%) | ||
| Increase in hypoglycemia (1 × 5-step scale) | 3 (11.5%) | 8 (19.5%) | ||
| Increase in hypoglycemia (2 × 5-step scale) | 3 (7.3%) | |||
| Missing | 8 | 2 | ||
| Number of days between CGM start and hypoglycemia follow-up datec | 434.0 (449.0) | 1056 (431) | ||
| 199.5 | 1022 | |||
| (6.0; 1501.0) | (356; 1748) | |||
| n = 26 | n = 41 | |||
a
Wilcoxonsigned-ranktestforchangefromCGMstarttofollow-uphypoglycemiavalue: long-termCGM: p = .0042
b
Wilcoxonsigned-ranktestforchangefromCGMstarttofollow-uphypoglycemiavalue: short-termCGM: p = .9142
c
Forcontinuousvariables, mean(SD) / median/ (minimum; maximum) / narepresented.